Akari Therapeutics Plc (AKTX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.02B
EV to revenue ratio (TTM)
400,346.36
EV to ebitda
-0.06
Financial Performance
Revenue (TTM)
$0B
Gross profit (TTM)
$0B
EBITDA
-$0.01B
Profitability
Operating margin (TTM)
<0.01%
Profit margin
<0.01%
Return on assets (TTM)
-19.10%
Return on equity (TTM)
-140.10%
Per Share Metrics
Revenue per share (TTM)
$0
EPS
$0
Diluted EPS (TTM)
$0
Book value
$10.62
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
0
Price to sales ratio (TTM)
478,368.50
Price to book ratio (TTM)
0.91
Growth
Quarterly earnings growth (YoY)
<0.01%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
1
Buy
1
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.47